|
|
|
|
Arkema's EVA price increase
- Arkema is implementing a price increase of 80/T (110 $/T) , for all Evatane resins (High Content Ethylene Vinyl Acetate Copolymers).This increase will take effect globally on 1st April 2010, or as customer contracts allow. The reason for this price...
|
|
|
Teva Pharmaceutical announces clinical study results of Copaxone in RRMS patients
Teva Pharmaceutical Industries Ltd.(NASDAQ: TEVA) today announced the publication of data from the 15-year clinical study with Copaxone (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning.The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety of the New...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that NASDAQ has halted trading of the Company?s common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
BusinessWire - Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the efficacy and safety...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Companies mentioned in this article: Salix Pharmaceuticals, Ltd.RALEIGH, N.C. -- (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
FDA Advisory Committee Reviewing XIFAXAN (rifaximin) Tablets, 550 mg NDA Buzz up!Companies: Related Quotes {"s" : "slxp","k" : "c10,l10,p20,t10","o" : "","j" : ""} RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd! (NASDAQ:SLXP - News) today...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.- (Business Wire) Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
RALEIGH, N.C.- (BUSINESS WIRE) - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA is meeting today to discuss the...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
Salix Pharmaceuticals Ltd (SLXP) Stock Quote, Chart, News, Add to Watchlist Salix Pharmaceuticals, Ltd.SLXP today announced that NASDAQ has halted trading of the Companys common stock this morning. The Gastrointestinal Drugs Advisory Committee of the FDA...
|
|
|
NASDAQ Halts Trading Today in Salix Pharmaceuticals Stock
FDA Advisory Committee Reviewing XIFAXAN (rifaximin) Tablets, 550 mg NDA Salix Pharmaceuticals, Ltd.(NASDAQ:SLXP) today announced that NASDAQ has halted trading of the Company's common stock this morning. The Gastrointestinal Drugs Advisory Committee of...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
- Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: Interested parties can access a live audio web cast...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.-- (BUSINESS WIRE) -- (NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010.Information on these conferences is provided below: RBC Capital Markets Healthcare Conference New...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
BusinessWire - Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital Markets Healthcare...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: Interested parties...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences
Salix Pharmaceuticals, Ltd.SLXP today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: Interested parties can access a live audio web cast of these...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP - News) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
Salix Pharmaceuticals, Ltd.(NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: RBC Capital Markets Healthcare Conference New York, N...
|
|
|
Salix Pharmaceuticals to Present at Three Investment Conferences in March
RALEIGH, N.C.- (BUSINESS WIRE) - Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that the Company will present at three health care investment conferences during March 2010. Information on these conferences is provided below: Interested...
|
|
|
Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated C
Daniel C.Danila, Michael J. Morris, Johann S. de Bono, Charles J. Ryan, Samuel R. Denmeade, Matthew R. Smith, Mary-Ellen Taplin, Glenn J. Bubley, Thian Kheoh, Christopher Haqq, Arturo Molina, Aseem Anand, Michael Koscuiszka, Steve M. Larson,...
|
|
|
Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients
Charles J.Ryan,* Matthew R. Smith, Lawrence Fong, Jonathan E. Rosenberg, Philip Kantoff, Florence Raynaud, Vanessa Martins, Gloria Lee, Thian Kheoh, Jennifer Kim, Arturo Molina, and Eric J. Small From the Urologic Oncology Program, University of...
|
|
|
Celanese Announces Ethylene Vinyl Acetate Price Increases
- Celanese Corporation announced that its subsidiary, Celanese EVA Performance Polymers Inc., will increase the price of all grades of LDPE by $0.05/pound effective March 1, 2010, or as contracts allow.long_space Additional information Celanese Corporation...
|
|
|
Ulipristal Acetate is Effective for Emergency Contraception
Not a member yet?HealthandAge member? please Or By: June Chen, MD Emergency contraception, sometimes referred to as the morning after pill, is birth control that can be used to prevent pregnancy after unprotected intercourse? The most widely-used...
|
|
|
Ulipristal Acetate Effective for Contraception up to 120 Hours After Intercourse
_ Ulipristal Acetate Effective for Contraception up to 120 Hours After Intercourse.
|
|
|
Ulipristal Acetate Effective for Contraception up to 120 Hours After Intercourse
_ Ulipristal Acetate Effective for Contraception up to 120 Hours After Intercourse.
|
